KI
HAE icon

Kapitalo Investimentos’s Haemonetics HAE Stock Holding History

Kapitalo Investimentos’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,636
Closed -$311K – 387
2023
Q4 		$311K Buy
3,636
+1,621
+80% +$140K 0.06% 180
2023
Q3 		$181K Sell
2,015
-785
-28% -$70.1K 0.02% 308
2023
Q2 		$238K Buy
+2,800
New +$237K 0.04% 210

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kapitalo Investimentos's HAE Position: Q1 2024 in Review

Kapitalo Investimentos sold out of Haemonetics (HAE) in Q1 2024, closing a stake of 3,636 shares — an estimated $311K sold.

Kapitalo Investimentos first reported a position in HAE in Q2 2023 and held it in 3 quarters. The position peaked at $311K in Q4 2023. 298 funds tracked by Wall St. Rank hold HAE as of Q1 2024.

  • Kapitalo Investimentos reported no remaining Haemonetics position as of Q1 2024 after selling out during the quarter.
  • Kapitalo Investimentos sold 3,636 Haemonetics shares in Q1 2024, an estimated $311K.
  • Kapitalo Investimentos first reported a position in Haemonetics in Q2 2023 and held it in 3 quarters.
  • Kapitalo Investimentos's Haemonetics position peaked at $311K in Q4 2023.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q1 2024.

Based on Kapitalo Investimentos's 13F filing for Q1 2024, filed 15 May 2024.